MIT Holding, Inc. (MITD) Innovative Healthcare Mod
Post# of 36
Posted On: 04/10/2015 4:45:25 PM
MIT Holding, Inc. (MITD) Innovative Healthcare Model Boasts Tri-Fold Effect
MIT Holding has carefully established a network of agents, facilitators and contractual obligations through which it believes is the opportunity to greatly enhance the healthcare industry. The Los Angeles-based company is a single-source provider for medical recovery services, specifically for the fourth and fifth phases of medical recovery: the dependent patient and recovery/rehabilitation stages.
Here’s how it works. An MIT representative meets with the hospital discharge planner and patient on the day of the patient’s discharge from the medical facility. This representative takes full responsibility in arranging in home or local clinic appointments, medication, medical equipment needs and insurance approvals for the patient, enabling them to focus on the recovery at hand without additional stress. In most cases, the products and services offered by MIT are already pre-approved by the patient’s health insurance, which enables the company to directly bill and receive payments from carriers on behalf of the patient as well as company agents and facilitators.
The company’s current line of services includes professional outpatient medical care such patient pharmaceuticals, intravenous infusions, medical management services, and in-home or ambulatory center therapies. In addition, durable medical equipment services (DME) enable the company to offer for sale or rent, home medical equipment, from crutches to hospital beds.
MIT also offers legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; and travel and transportation services of medically challenged patients for medical needs and personal travel.
Need for these services arise from pressure for doctors and hospitals to lower costs, which results in patients being released from the hospital earlier to reduce the cost of care.
By offering a complete need-fulfillment for the patient during their at home recovery period, MIT’s services assists the patient through recovery, helps healthcare facilities lower their costs, and creates opportunities to cross market its goods and services to enhance revenues streams.
Following a successful reorganization initiative launched at the start of last year, MIT is now positioned to achieve 32% minimum net profits and maintain profitability. This profitability validates the company’s business model and its approach to the evolving health services industry.
According to the latest figures from the Centers for Disease Control (CDC), in 2013 more than 35 million patients were discharged after a nearly five-day stay in a non-federal hospital. The same year, outpatient services exceeded 100 million patients in non-federal facilities. Based on these figures, MIT is tackling a market opportunity of more than 135 million patients to which it can cross market its invaluable products and services while working toward its broader mission to lead medical and technological innovations to enhance the physical, emotional and aesthetic quality of life.
For more information, visit www.mitholdinginc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
MIT Holding has carefully established a network of agents, facilitators and contractual obligations through which it believes is the opportunity to greatly enhance the healthcare industry. The Los Angeles-based company is a single-source provider for medical recovery services, specifically for the fourth and fifth phases of medical recovery: the dependent patient and recovery/rehabilitation stages.
Here’s how it works. An MIT representative meets with the hospital discharge planner and patient on the day of the patient’s discharge from the medical facility. This representative takes full responsibility in arranging in home or local clinic appointments, medication, medical equipment needs and insurance approvals for the patient, enabling them to focus on the recovery at hand without additional stress. In most cases, the products and services offered by MIT are already pre-approved by the patient’s health insurance, which enables the company to directly bill and receive payments from carriers on behalf of the patient as well as company agents and facilitators.
The company’s current line of services includes professional outpatient medical care such patient pharmaceuticals, intravenous infusions, medical management services, and in-home or ambulatory center therapies. In addition, durable medical equipment services (DME) enable the company to offer for sale or rent, home medical equipment, from crutches to hospital beds.
MIT also offers legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; and travel and transportation services of medically challenged patients for medical needs and personal travel.
Need for these services arise from pressure for doctors and hospitals to lower costs, which results in patients being released from the hospital earlier to reduce the cost of care.
By offering a complete need-fulfillment for the patient during their at home recovery period, MIT’s services assists the patient through recovery, helps healthcare facilities lower their costs, and creates opportunities to cross market its goods and services to enhance revenues streams.
Following a successful reorganization initiative launched at the start of last year, MIT is now positioned to achieve 32% minimum net profits and maintain profitability. This profitability validates the company’s business model and its approach to the evolving health services industry.
According to the latest figures from the Centers for Disease Control (CDC), in 2013 more than 35 million patients were discharged after a nearly five-day stay in a non-federal hospital. The same year, outpatient services exceeded 100 million patients in non-federal facilities. Based on these figures, MIT is tackling a market opportunity of more than 135 million patients to which it can cross market its invaluable products and services while working toward its broader mission to lead medical and technological innovations to enhance the physical, emotional and aesthetic quality of life.
For more information, visit www.mitholdinginc.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)